tirzepatide recall Lilly launches lower-price weight loss drug without injector pen May 18, 2026: FDA warns

Your brain doesnt get the same pleasure signal from alcohol

Tirzepatide, the generic version of Mounjaro, is an FDA-approved antidiabetic medication used for the treatment of type 2 diabetes and has shown promising results in studies to help with weight loss even for people without diabetes

Staying at your current dose for an extra 2 to 4 weeks does not reduce long-term weight loss effectiveness

As modern lifestyles expose us to pollutants, processed foods, and chronic stress , glutathione levels can decline over time

God bless and thank you. [276] [277] Ventures and interests A supporter of NASA's crewed space program, Hanks said he originally wanted to be an astronaut

Structural, functional, and molecular characterization of the SHHF model of heart failure